626 Financial’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
626 Financial's BMY Position: Q3 2026 in Review
626 Financial increased its Bristol-Myers Squibb (BMY) stake by 0.05% in Q3 2026, buying an estimated $379 and bringing the position to 12,378 shares worth $772K. The position accounts for 0.3% of the portfolio, ranked #53.
626 Financial first reported a position in BMY in Q1 2021 and has held it in 21 quarters since. The position peaked at $865K in Q1 2026. 1,520 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- 626 Financial held 12,378 shares of Bristol-Myers Squibb worth $772K as of Q3 2026.
- 626 Financial bought 6 Bristol-Myers Squibb shares in Q3 2026, an estimated $379.
- Bristol-Myers Squibb made up 0.3% of 626 Financial's portfolio in Q3 2026, its #53 holding.
- 626 Financial first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 21 quarters since.
- 626 Financial's Bristol-Myers Squibb position peaked at $865K in Q1 2026.
- 1,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on 626 Financial's 13F filing for Q3 2026, filed 4 Nov 2026.